Healthy Extracts (HYEX) Total Non-Current Liabilities (2015 - 2026)
Healthy Extracts (HYEX) posted quarterly Total Non-Current Liabilities of $2.1 million for Q4 2025, up 235.58% year-over-year from $627847.0 in Q4 2024, and up 120.42% quarter-over-quarter from $955856.0 in Q3 2025.
Healthy Extracts (HYEX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
Healthy Extracts' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 235.58% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (up 235.58% YoY), while the FY2025 annual figure was $2.1 million, up 235.58% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $2.1 million, up from $955856.0 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $2.9 million in Q4 2021, with the low at -$910779.0 in Q1 2024.
- The 5-year median for Total Non-Current Liabilities is $1.4 million (2023), against an average of $1.3 million.
- The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities soared 1780.25% in 2021, then plunged 1279.58% in 2023.
- Healthy Extracts' Total Non-Current Liabilities stood at $2.9 million in 2021, then slipped by 10.56% to $2.6 million in 2022, then fell by 5.56% to $2.5 million in 2023, then plunged by 74.69% to $627847.0 in 2024, then jumped by 235.58% to $2.1 million in 2025.
- Business Quant data shows HYEX's Total Non-Current Liabilities at $2.1 million in Q4 2025, $955856.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 334.00 Mn |
| 10 | Healthy Extracts | 19.12 Mn | 18.93 Mn | 1.45 Mn | 1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.78 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 955,856.00 |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 627,847.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | -736,623.00 |
| Mar 31, 2024 | -910,779.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | -186,919.00 |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | -13,549.00 |
| Dec 31, 2021 | 2.94 Mn |
| Sep 30, 2021 | 2.14 Mn |
| Jun 30, 2021 | 2.62 Mn |